Vocxi Health partnered with S3 Connected Health on its smart BreathEZ device, designed to detect lung cancer from volatile organic compounds with just one minute of breathing. [Image courtesy of Vocxi Health]
NEWS RELEASE: Vocxi Health and S3 Connected Health partner on lung cancer screening and monitoring
Vocxi Health, a breath diagnostics company focused on accurate, non-invasive disease identification, has partnered with S3 Connected Health, the specialist digital health partner for life science companies, to bring game-changing technology to market to transform lung cancer detection and monitoring.
Vocxi Health has patented technology to deliver a smart device, the BreathEZ, designed to detect lung cancer from volatile organic compounds with just one minute of breathing. This breakthrough technology aims to make late-stage diagnoses a thing of the past, promising earlier detection and improved outcomes for patients. Lung cancer is responsible for over 1.8 million deaths globally every year, but early detection leads to a 10X improvement in survival rates.
Vocxi Health has partnered with S3 Connected Health for full end-to-end delivery of their digital health solution, and S3 Connected Health’s digital health platform Affinial, the most comprehensive platform for life science companies to create regulated digital health solutions, will be used as the basis upon which the custom mobile app and cloud-based solution will be built. Vocxi Health also plans to leverage Affinial’s efficiencies in scaling solutions to facilitate their future plans for the BreathEZ, including potential expansion into other disease areas.
Bill Betten, director of medtech solutions at S3 Connected Health, who has been working closely with Vocxi on this, said, ”This is an exciting journey upon which we’re embarking with Vocxi. It is a game-changing product that takes full advantage of our digital health system capabilities, including rapid deployment via our Affinial platform while providing a base for future growth to match Vocxi’s plans.”
Randy Schiestl, COO and board director at Vocxi Health, stated, “We have proprietary technology, an experienced and motivated core team, trusted advisors and global partners to meet commercialization objectives. Vocxi partnering with S3 Connected Health has enabled the team to integrate mobile and cloud connectivity with confidence.”
Vocxi Health
Vocxi Health, established in Q3 2022, is a disease diagnostic start-up launched from the University of Minnesota Technology Commercialization office. Located in Arden Hills, Minnesota, Vocxi Health has formed a successful health technology core team that has integrated multiple global development, regulatory, quality and manufacturing partners to commercialize innovative breath-sensing technologies to improve the outcomes for people at high risk for disease.
S3 Connected Health
S3 Connected Health is the specialist digital health partner for life science companies, developing regulated digital health solutions that improve the lives of people with acute and chronic conditions. It has delivered award-winning, regulatory-compliant solutions across 20 therapy areas and in more than 50 countries, from its offices in the US, Ireland, and Poland. From definition and development, through to launch and operation, we make sure your product or device makes a meaningful impact on health outcomes and the delivery of care. Affinial, S3 Connected Health’s digital health platform, offers partners the opportunity to develop customized digital health solutions tailored to specific patient, device, or disease needs. The platform’s pre-built services can be customized and implemented with reduced costs and shorter time-to-market.
The opinions expressed in this news release are the author’s only and do not necessarily reflect those of Medical Design & Outsourcing or its employees.